Clinical Trial Update: Coronavirus Anxiety in Patients Using Biologic vs Conventional DMARDs

View source ↗

Summary

A completed clinical trial comparing anxiety and COVID-19-related outcomes in patients treated with biologic DMARDs versus conventional DMARDs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Rheumatic Diseases

Drugs mentioned

• Biologic DMARDs
• Conventional synthetic DMARDs

Snippet

Sponsor: Bursa City Hospital | Conditions: COVID-19, Anxiety | Status: COMPLETED